K. Tsuruzoe

发表

Effects of olmesartan, an angiotensin II receptor blocker, on peripheral insulin sensitivity in Japanese subjects with type 2 diabetes and hypertension.

E. Araki, S. Iwashita, K. Nishida, 2012, Internal medicine.

Impact of Mitochondrial Reactive Oxygen Species and Apoptosis Signal–Regulating Kinase 1 on Insulin Signaling

H. Ichijo, E. Araki, T. Matsumura, 2006, Diabetes.

Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes

H. Motoshima, E. Araki, K. Sakai, 2003, Diabetologia.

Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma

T. Kondo, E. Araki, H. Motoshima, 2016, Endocrinology, diabetes & metabolism case reports.

Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.

J. Miyazaki, H. Motoshima, M. Shichiri, 1998, Diabetes.

Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes.

C. Kahn, E. Araki, T. Shirotani, 2002, The Journal of endocrinology.

Cell-Specific Regulation of IRS-1 Gene Expression: Role of E Box and C/EBP Binding Site in HepG2 Cells and CHO Cells

E. Araki, H. Motoshima, M. Shichiri, 1997, Diabetes.

AICAR, an activator of AMP-activated protein kinase, down-regulates the insulin receptor expression in HepG2 cells.

E. Araki, H. Motoshima, Kazuya Matsumoto, 2005, Biochemical and biophysical research communications.

A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy.

E. Araki, F. Sakamoto, M. Sakakida, 2006, Diabetes research and clinical practice.

Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice.

E. Araki, K. Kume, S. Kume, 2005, Biochemical and biophysical research communications.

Heat shock treatment with mild electrical stimulation safely reduced inflammatory markers in healthy male subjects.

H. Kai, E. Araki, H. Motoshima, 2010, Obesity research & clinical practice.

A carboxy-terminal truncation of human alpha-galactosidase A in a heterozygous female with Fabry disease and modification of the enzymatic activity by the carboxy-terminal domain. Increased, reduced, or absent enzyme activity depending on number of amino acid residues deleted.

M. Shichiri, E. Araki, T. Shirotani, 1996, The Journal of clinical investigation.

Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis.

S. Yamashita, T. Suda, M. Tabata, 2009, Biochemical and biophysical research communications.

Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice.

E. Araki, Norio Ishii, T. Matsumura, 2011, Biochemical and biophysical research communications.

Insulin Receptor Substrate 3 (IRS-3) and IRS-4 Impair IRS-1- and IRS-2-Mediated Signaling

K. Ueki, R. Emkey, K. Kriauciunas, 2001, Molecular and Cellular Biology.

Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway.

C. Kahn, E. Araki, T. Toyonaga, 2003, The Journal of endocrinology.

Impact of Natural IRS-1 Mutations on Insulin Signals: Mutations of IRS-1 in the PTB Domain and Near SH2 Protein Binding Sites Result in Impaired Function at Different Steps of IRS-1 Signaling

E. Araki, H. Motoshima, M. Shichiri, 1997, Diabetes.

IRS-1 transgenic mice show increased epididymal fat mass and insulin resistance.

C. Kahn, E. Araki, H. Motoshima, 2007, Biochemical and biophysical research communications.

Oxidized Low Density Lipoprotein Activates Peroxisome Proliferator-activated Receptor-α (PPARα) and PPARγ through MAPK-dependent COX-2 Expression in Macrophages*

E. Araki, Norio Ishii, T. Matsumura, 2008, Journal of Biological Chemistry.

Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice.

E. Araki, T. Matsumura, H. Motoshima, 2008, Biochemical and biophysical research communications.

Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues.

K. Inukai, E. Araki, T. Matsumura, 2008, Biochemical and biophysical research communications.

A case of primary thyroid squamous cell cancer: transformation from benign tumour associated with chronic thyroiditis?

E. Araki, K. Iyama, Y. Honda, 2009, BMJ Case Reports.

A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study)

E. Araki, Norio Ishii, T. Matsumura, 2016, Journal of diabetes investigation.

Possible involvement of atypical protein kinase C (PKC) in glucose-sensitive expression of the human insulin gene: DNA-binding activity and transcriptional activity of pancreatic and duodenal homeobox gene-1 (PDX-1) are enhanced via calphostin C-sensitive but phorbol 12-myristate 13-acetate (PMA) an

H. Motoshima, M. Shichiri, E. Araki, 1999, Endocrine journal.

Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression

T. Asano, E. Araki, T. Matsumura, 2005, Circulation research.

An acylic polyisoprenoid derivative, geranylgeranylacetone protects against visceral adiposity and insulin resistance in high-fat-fed mice.

H. Kai, E. Araki, H. Motoshima, 2010, American journal of physiology. Endocrinology and metabolism.

A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases.

E. Araki, H. Motoshima, K. Iyama, 2010, Endocrine journal.

The impact of Ca²⁺/calmodulin-dependent protein kinase II on insulin gene expression in MIN6 cells.

E. Araki, Kazuya Matsumoto, S. Shimoda, 2012, Biochemical and biophysical research communications.

An acylic polyisoprenoid derivative, geranylgeranylacetone protects against visceral adiposity and insulin resistance in high-fat-fed mice.

H. Kai, E. Araki, H. Motoshima, 2010, American journal of physiology. Endocrinology and metabolism.

Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues.

K. Inukai, E. Araki, T. Matsumura, 2008, Biochemical and biophysical research communications.